Mutations in the riboflavin biosynthesis pathway confer resistance to furazolidone and abolish the synergistic interaction between furazolidone and vancomycin in Escherichia coli
Sign Up to like & getrecommendations! Published in 2025 at "Microbial Genomics"
DOI: 10.1099/mgen.0.001356
Abstract: Abstract The combined application of furazolidone and vancomycin has previously been shown to be synergistic against Gram-negative pathogens, with great therapeutic promise. However, the emergence and mechanism of resistance to this antibiotic combination have not… read more here.
Keywords: resistance; furazolidone vancomycin; ribb ribe; riboflavin biosynthesis ... See more keywords